High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial

Abstract Background Interstitial lung disease is a debilitating condition associated with significant dyspnoea, fatigue, and poor exercise tolerance. Pulmonary rehabilitation is an effective and key intervention in people with interstitial lung disease. However, despite the best efforts of patients...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Leona M. Dowman, Anthony K. May, Catherine J. Hill, Janet Bondarenko, Lissa Spencer, Norman R. Morris, Jennifer A. Alison, James Walsh, Nicole S. L. Goh, Tamera Corte, Ian Glaspole, Daniel C. Chambers, Christine F. McDonald, Anne E. Holland
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/52176e3613c54b9ba80389837f3ac23d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:52176e3613c54b9ba80389837f3ac23d
record_format dspace
spelling oai:doaj.org-article:52176e3613c54b9ba80389837f3ac23d2021-11-14T12:37:16ZHigh intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial10.1186/s12890-021-01704-21471-2466https://doaj.org/article/52176e3613c54b9ba80389837f3ac23d2021-11-01T00:00:00Zhttps://doi.org/10.1186/s12890-021-01704-2https://doaj.org/toc/1471-2466Abstract Background Interstitial lung disease is a debilitating condition associated with significant dyspnoea, fatigue, and poor exercise tolerance. Pulmonary rehabilitation is an effective and key intervention in people with interstitial lung disease. However, despite the best efforts of patients and clinicians, many of those who participate are not achieving clinically meaningful benefits. This assessor-blinded, multi-centre, randomised controlled trial aims to compare the clinical benefits of high intensity interval exercise training versus the standard pulmonary rehabilitation method of continuous training at moderate intensity in people with fibrotic interstitial lung disease. Methods Eligible participants will be randomised to either a standard pulmonary rehabilitation group using moderate intensity continuous exercise training or high intensity interval exercise training. Participants in both groups will undertake an 8-week pulmonary rehabilitation program of twice-weekly supervised exercise training including aerobic (cycling) and strengthening exercises. In addition, participants in both groups will be prescribed a home exercise program. Outcomes will be assessed at baseline, upon completion of the intervention and at six months following the intervention by a blinded assessor. The primary outcome is endurance time on a constant work rate test. Secondary outcomes are functional capacity (6-min walk distance), health-related quality of life (Chronic Respiratory Disease Questionnaire (CRQ), St George’s Respiratory Questionnaire idiopathic pulmonary fibrosis specific version (SGRQ-I), breathlessness (Dyspnoea 12, Modified Medical Research Council Dyspnoea Scale), fatigue (fatigue severity scale), anxiety (Hospital Anxiety and Depression Scale), physical activity level (GeneActiv), skeletal muscle changes (ultrasonography) and completion and adherence to pulmonary rehabilitation. Discussion The standard exercise training strategies used in pulmonary rehabilitation may not provide an optimal exercise training stimulus for people with interstitial lung disease. This study will determine whether high intensity interval training can produce equivalent or even superior changes in exercise performance and symptoms. If high intensity interval training proves effective, it will provide an exercise training strategy that can readily be implemented into clinical practice for people with interstitial lung disease. Trial registration ClinicalTrials.gov Registry (NCT03800914). Registered 11 January 2019, https://clinicaltrials.gov/ct2/show/NCT03800914 Australian New Zealand Clinical Trials Registry ACTRN12619000019101. Registered 9 January 2019, https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=376050&isReview=trueLeona M. DowmanAnthony K. MayCatherine J. HillJanet BondarenkoLissa SpencerNorman R. MorrisJennifer A. AlisonJames WalshNicole S. L. GohTamera CorteIan GlaspoleDaniel C. ChambersChristine F. McDonaldAnne E. HollandBMCarticleInterstitial lung diseasesIdiopathic pulmonary fibrosisPulmonary FibrosisExercise,RehabilitationHigh-Intensity interval trainingDiseases of the respiratory systemRC705-779ENBMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Interstitial lung diseases
Idiopathic pulmonary fibrosis
Pulmonary Fibrosis
Exercise,
Rehabilitation
High-Intensity interval training
Diseases of the respiratory system
RC705-779
spellingShingle Interstitial lung diseases
Idiopathic pulmonary fibrosis
Pulmonary Fibrosis
Exercise,
Rehabilitation
High-Intensity interval training
Diseases of the respiratory system
RC705-779
Leona M. Dowman
Anthony K. May
Catherine J. Hill
Janet Bondarenko
Lissa Spencer
Norman R. Morris
Jennifer A. Alison
James Walsh
Nicole S. L. Goh
Tamera Corte
Ian Glaspole
Daniel C. Chambers
Christine F. McDonald
Anne E. Holland
High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial
description Abstract Background Interstitial lung disease is a debilitating condition associated with significant dyspnoea, fatigue, and poor exercise tolerance. Pulmonary rehabilitation is an effective and key intervention in people with interstitial lung disease. However, despite the best efforts of patients and clinicians, many of those who participate are not achieving clinically meaningful benefits. This assessor-blinded, multi-centre, randomised controlled trial aims to compare the clinical benefits of high intensity interval exercise training versus the standard pulmonary rehabilitation method of continuous training at moderate intensity in people with fibrotic interstitial lung disease. Methods Eligible participants will be randomised to either a standard pulmonary rehabilitation group using moderate intensity continuous exercise training or high intensity interval exercise training. Participants in both groups will undertake an 8-week pulmonary rehabilitation program of twice-weekly supervised exercise training including aerobic (cycling) and strengthening exercises. In addition, participants in both groups will be prescribed a home exercise program. Outcomes will be assessed at baseline, upon completion of the intervention and at six months following the intervention by a blinded assessor. The primary outcome is endurance time on a constant work rate test. Secondary outcomes are functional capacity (6-min walk distance), health-related quality of life (Chronic Respiratory Disease Questionnaire (CRQ), St George’s Respiratory Questionnaire idiopathic pulmonary fibrosis specific version (SGRQ-I), breathlessness (Dyspnoea 12, Modified Medical Research Council Dyspnoea Scale), fatigue (fatigue severity scale), anxiety (Hospital Anxiety and Depression Scale), physical activity level (GeneActiv), skeletal muscle changes (ultrasonography) and completion and adherence to pulmonary rehabilitation. Discussion The standard exercise training strategies used in pulmonary rehabilitation may not provide an optimal exercise training stimulus for people with interstitial lung disease. This study will determine whether high intensity interval training can produce equivalent or even superior changes in exercise performance and symptoms. If high intensity interval training proves effective, it will provide an exercise training strategy that can readily be implemented into clinical practice for people with interstitial lung disease. Trial registration ClinicalTrials.gov Registry (NCT03800914). Registered 11 January 2019, https://clinicaltrials.gov/ct2/show/NCT03800914 Australian New Zealand Clinical Trials Registry ACTRN12619000019101. Registered 9 January 2019, https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=376050&isReview=true
format article
author Leona M. Dowman
Anthony K. May
Catherine J. Hill
Janet Bondarenko
Lissa Spencer
Norman R. Morris
Jennifer A. Alison
James Walsh
Nicole S. L. Goh
Tamera Corte
Ian Glaspole
Daniel C. Chambers
Christine F. McDonald
Anne E. Holland
author_facet Leona M. Dowman
Anthony K. May
Catherine J. Hill
Janet Bondarenko
Lissa Spencer
Norman R. Morris
Jennifer A. Alison
James Walsh
Nicole S. L. Goh
Tamera Corte
Ian Glaspole
Daniel C. Chambers
Christine F. McDonald
Anne E. Holland
author_sort Leona M. Dowman
title High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial
title_short High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial
title_full High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial
title_fullStr High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial
title_full_unstemmed High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial
title_sort high intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial
publisher BMC
publishDate 2021
url https://doaj.org/article/52176e3613c54b9ba80389837f3ac23d
work_keys_str_mv AT leonamdowman highintensityintervaltrainingversusmoderateintensitycontinuoustrainingforpeoplewithinterstitiallungdiseaseprotocolforarandomisedcontrolledtrial
AT anthonykmay highintensityintervaltrainingversusmoderateintensitycontinuoustrainingforpeoplewithinterstitiallungdiseaseprotocolforarandomisedcontrolledtrial
AT catherinejhill highintensityintervaltrainingversusmoderateintensitycontinuoustrainingforpeoplewithinterstitiallungdiseaseprotocolforarandomisedcontrolledtrial
AT janetbondarenko highintensityintervaltrainingversusmoderateintensitycontinuoustrainingforpeoplewithinterstitiallungdiseaseprotocolforarandomisedcontrolledtrial
AT lissaspencer highintensityintervaltrainingversusmoderateintensitycontinuoustrainingforpeoplewithinterstitiallungdiseaseprotocolforarandomisedcontrolledtrial
AT normanrmorris highintensityintervaltrainingversusmoderateintensitycontinuoustrainingforpeoplewithinterstitiallungdiseaseprotocolforarandomisedcontrolledtrial
AT jenniferaalison highintensityintervaltrainingversusmoderateintensitycontinuoustrainingforpeoplewithinterstitiallungdiseaseprotocolforarandomisedcontrolledtrial
AT jameswalsh highintensityintervaltrainingversusmoderateintensitycontinuoustrainingforpeoplewithinterstitiallungdiseaseprotocolforarandomisedcontrolledtrial
AT nicoleslgoh highintensityintervaltrainingversusmoderateintensitycontinuoustrainingforpeoplewithinterstitiallungdiseaseprotocolforarandomisedcontrolledtrial
AT tameracorte highintensityintervaltrainingversusmoderateintensitycontinuoustrainingforpeoplewithinterstitiallungdiseaseprotocolforarandomisedcontrolledtrial
AT ianglaspole highintensityintervaltrainingversusmoderateintensitycontinuoustrainingforpeoplewithinterstitiallungdiseaseprotocolforarandomisedcontrolledtrial
AT danielcchambers highintensityintervaltrainingversusmoderateintensitycontinuoustrainingforpeoplewithinterstitiallungdiseaseprotocolforarandomisedcontrolledtrial
AT christinefmcdonald highintensityintervaltrainingversusmoderateintensitycontinuoustrainingforpeoplewithinterstitiallungdiseaseprotocolforarandomisedcontrolledtrial
AT anneeholland highintensityintervaltrainingversusmoderateintensitycontinuoustrainingforpeoplewithinterstitiallungdiseaseprotocolforarandomisedcontrolledtrial
_version_ 1718429105108549632